Emerging Anti-Diabetic Drugs for Beta-Cell Protection in Type 1 Diabetes

Type 1 diabetes (T1D) is a chronic autoimmune disorder that damages beta cells in the pancreatic islets of Langerhans and results in hyperglycemia due to the loss of insulin. Exogenous insulin therapy can save lives but does not halt disease progression. Thus, an effective therapy may require beta-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ajmal, Nida, Bogart, Maislin C., Khan, Palwasha, Max-Harry, Ibiagbani M., Nunemaker, Craig S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253164/
https://www.ncbi.nlm.nih.gov/pubmed/37296593
http://dx.doi.org/10.3390/cells12111472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253164/
https://www.ncbi.nlm.nih.gov/pubmed/37296593
http://dx.doi.org/10.3390/cells12111472

Ejemplares similares